Search

Your search keyword '"Breen DM"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Breen DM" Remove constraint Author: "Breen DM"
34 results on '"Breen DM"'

Search Results

1. Spontaneous Breathing in Early Acute Respiratory Distress Syndrome

2. Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database

3. Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries

4. Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

5. Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production.

6. Frequency of weight and body composition increases in advanced non-small cell lung cancer patients during first line therapy.

7. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.

8. Body composition and lung cancer-associated cachexia in TRACERx.

9. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.

10. Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.

11. Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation.

12. Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model.

13. GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates.

14. Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPK.

15. Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivo.

16. High-dose metformin (420mg/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis.

17. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.

18. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.

19. Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.

20. In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity.

21. Latest approaches for the treatment of obesity.

22. Jejunal leptin-PI3K signaling lowers glucose production.

23. Local insulin application on the carotid artery inhibits neointima formation.

24. Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes.

25. Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.

26. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes.

27. Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats.

28. Lipid sensing in the gut, brain and liver.

29. Duodenal mucosal protein kinase C-δ regulates glucose production in rats.

30. Effects of insulin on the vasculature.

31. Gut-brain signalling: how lipids can trigger the gut.

32. Insulin inhibits and oral sucrose increases neointimal growth after arterial injury in rats.

33. Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury.

34. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK.

Catalog

Books, media, physical & digital resources